Late-onset neutropenia following rituximab therapy: incidence, clinical features and possible mechanisms
A high incidence of late-onset neutropenia following rituximab-containing chemotherapy as a primary treatment of CD20-positive B-cell lymphoma: a single-institution study
Late-life depression: the differences between early- and late-onset illness in a community-based sample
Prognosis of early-onset versus late-onset sporadic colorectal cancer: Systematic review and meta-analysis
